Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1900028380Phase 2Not yet recruiting
Phase 2, randomised, double-blind trial of Die-Da Sun-Shang ointment in Ankle sprain (2 arms), sponsored by Beijing Hospital of Traditional Chinese Medicine. Primary endpoint: Change in pain visual analog scale score from baseline at day 14. Planned start Feb 2020; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1900028380.